← All trials
NCT04478656
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 3, 2017
- Primary completion
- Nov 15, 2017
- Completion date
- Nov 15, 2018
- First posted
- Jul 21, 2020
- Last posted
- Oct 22, 2020
- Enrollment
- 48
- Arms / groups
- 4 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Bharat Biotech International LimitedLead sponsor
- Bharat Biotech International LimitedStudy chair
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.